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List of abbreviations 
 
ATP: adenosine triphosphate 
β2-AR: β2-adrenergic receptor 
Ca
2+
: calcium ion 
cAMP: cyclic adenosine monophosphate 
DAG: diacyl-glycerol 
E2: 17-beta-estradiol valerate 
GPCR: G-protein-coupled receptor 
IP3: inositole-1,4,5-triphoshate 
NADPH: nicotinamide adenine dinucleotide phosphate 
NOX: NADPH oxidases 
OS: oxidative stress 
OSI: oxidative stress index 
P4: progesterone 
PIP2: phosphatidyl-inositol-4,5-bisphosphate 
PKC: protein kinase C 
PM: plasma membrane 
PLC: phospholipase C 
ROS: reactive oxygen species 
RNS: reactive nitrogen species 
SMC: smooth muscle cells 
TOS: total oxidant status 
TAS: total antioxidant status 
Tris-HCl: tris-(hydroximethyl)-aminomethane hydrochloride 
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1. Introduction 
 
1.1. Free radicals and they role in cell signaling 
Free radicals is defined as any chemical species that contains unpaired electron in its outer 
orbit. Because of these unpaired electrons, they are highly reactive and readily take part in 
chemical reactions with all cell components (lipids, proteins and nucleic acids) in the body 
(Kohen et al. 2002). They are generated from physiological processes to produce energy and 
metabolites. In most biological systems, the free radicals of interest are often referred to as 
reactive oxygen species (ROS), as the most biologically significant free radicals are oxygen 
centered. There is another major group of free radicals which are nitrogen-centered, and many 
other free radical groups depending the nature of the compound (carbon, lipids and generic 
radical). Free radicals tend to be transformed into ROS, which are considered to be the most 
important reactive species (Robles et al. 2013). The reason for this transformation is that the 
final product of the reaction will be H2O, which has no toxic value. So the most commonly 
produced and well studied ROS are generated during the oxidative phosphorylation or one-
electron reduction of O2 in the mitochondria as natural byproduct. The apparent paradox in 
the roles of ROS as toxic byproducts of metabolism and as essential biomolecules in the 
regulation of cellular function may be related to differences in concentrations. They have 
many important biological functions in our body, some can even act as messengers through a 
phenomenon called redox signaling. They are ideally suited in many ways to be signalling 
molecules: they are small, and can diffuse short distances; there are several mechanisms for 
their production, some of which are rapid and controllable; and there are numerous 
mechanisms for their rapid removal (Thannickal VJ et al. 2000). Under normal conditions, 
ROS are safely neutralized by the antioxidant defense systems, including superoxide 
dismutase, catalase, glutathione peroxidases and glutathion reductase. These systems are 
complex, located in diferrent cellular compartments and are often redundant or 
complementary in various conditions. Oxidative stress occurs when the balance between 
antioxidants and ROS are disrupted because of either depletion of antioxidants or 
accumulation of ROS. When it is occur, cells attempt to counteract the oxidant effects and 
restore the redox balance by activation or silencing of genes encoding defensive enzymes, 
transcription factors, and structural proteins. Higher production of ROS in body may change 
DNA structure, result in modification of proteins and lipids, activation of several stress-
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induced transcription factors, and production of proinflammatory and anti-inflammatory 
cytokines (Birben et al. 2012).  
ROS inhibitors have emerging roles in the therapy and prevention of diseases, but may clearly 
have an impact on ROS-dependent physiological processes. Typical compounds with these 
characteristic include some vitamins, such as vitamin C and E, that have a direct activity like 
scavengers and also some indirect activities related to different mechanism that my have an 
impact on the OS. Tocopherol (vitamin E), a lipid-soluble membrane-localized antioxidant, 
prevents the propagation of free radical reactions and preserves cell membranes by reacting 
with lipid peroxyl radicals and undergoing conversion to a nonreactive tocopheroxyl radical. 
Tocopherol is one of the most frequently consumed antioxidants in both nutrition and dietary 
supplements. Moreover there are many extensive and varied structural compounds occurring 
in nature. Terpenes display a wide range of biological and pharmacological activities. 
Limonene is a major component of several plant essential oils, including orange, lemon, 
mandarin, lime and grapefruit. Because of its pleasant lemon-like sweet smell it is used 
widely as an additive in perfumes, soaps, foods, chewing gums and beverages (Lappas et al 
2012).  
There is mounting evidence over the past decade implicating ROS are important molecules in 
intracellular signal transduction. For example, the generation of ROS attenuates epidermal 
growth factor-mediated activation of extracellular signal-regulated kinase, leading to the 
suggestion that ROS production is an intrinsic signal transduction desensitizer (Maziere et al. 
2003). Moreover, the engagement of B cell receptors with immunoglobulin in lymphoma cells 
promotes ROS-dependent amplification of the cell signal, leading to the conclusion that ROS 
are rather signal transducers (Singh et al. 2005). They also play key roles in response to a 
variety of stimuli, including peptide growth factors and cytokines. ROS can also covalently 
modify proteins and such oxidative modifications, which can greatly alter protein function, 
have been implicated in certain conditions (Oberley 2003). In addition, hydrogen peroxide 
and superoxide that can mediate oxidative pathology also mediate changes in Ca
2+
-channel 
function via alterations of thiol groups (Hool et al. 2007). Agonist binding to certain tyrosine 
kinase and G protein-coupled receptors regulates production of ROS in turn, determine the 
nature and duration of the cell signal. In the case of GPCRs, the stimulation of the respective 
receptors linked to the formation of ROS (Thannickal and Fanburg 2000). Stimulation of 
several GPCRs such as muscarinic acetylcholine, angiotensin II-1, dopamine, as well as the 
serotonine receptors either increase or decrease ROS generation with significant downstream 
signaling consequences, suggesting that GPCR-mediated ROS signaling may have an 
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important role in homeostatic balance which may be altered in pathophysiological states 
(Mukhin et al. 2000, Yang et al. 2006). Moreover, β2 -AR agonists were shown to stimulate 
alterations in the redox states of the receptor (Marques et al. 1997). G protein mediated ERK 
1/2 phosphorytation was also blunted by ROS depletion, suggesting that ROS are 
indispensable for β2 -AR -mediated G protein signaling. A similar effect was seen with β2 -AR 
-mediated β-arrestin signaling. However, the inhibition of ROS attenuates β2-AR signal 
transduction, suggesting that a low level of intracellular ROS may influence the whole β2-AR 
signal transduction (Moniri et al 2007). Thus, ROS seems to act as second messengers of 
specific ligands, including different growth factors and adrenergic signaling (Corbi et al, 
2013). Previous study show, that acute β-adrenergic stimulation with isoproterenol induces a 
cAMP- and PKA-dependent increase in mitochondrial ROS production in intact ventricular 
mouse cardiomyocytes. In addition, this increase in ROS plays a crucial role in the β-
adrenergic inotropic effect, because the isoproterenol-induced increases in Ca2+ transient 
amplitude is diminished in the presence of the general antioxidant NAC. So isoproterenol is 
known to increase mitochondrial ROS production in the cardiomyocytes and this action is part 
of the β2-AR signal transduction (Andersson et al. 2011). 
 
1.2. Signal transduction pathways in smooth muscle 
 
Smooth muscle cells are a class of contractile cells with diverse phenotypes that are necessary 
for the proper function of many organs. The voltage-activated L-type calcium (Ca
2+
) channels 
at the plasma membrane (PM) play a central role in the function of SMC by controlling their 
contraction. Increase in intracellular Ca
2+ 
is attributed to stimulation of phospholipase C by 
activation of G protein-coupled plasma membrane receptors. This enzyme stimulates the 
breakdown of the membrane phospolipid phosphatidyl-inositol-4,5-bisphosphate (PIP2), 
resulting the production of the two intracellular second messengers inositole-1,4,5-triphoshate 
(IP3) and diacyl-glycerol (DAG). IP3 diffuses through the cytosol and binds to specific sites 
on intracellular calcium stores, resulting in relesase of Ca
2+ 
into the cytoplasm. DAG, the 
other product of PIP2 hydrolysis, is able to activate protein kinase C (PKC), may also be able 
to stimulate Ca
2+
 entry (Fig.1.). SMC also express nonvoltage-dependent Ca
2+
 channels that 
are typically activated by mechanical stimuli or downstream of phospholipase C (PLC) 
isoforms in response to stimulation by vasoactive and growth factor receptors (Chung et al. 
2000). These intracellular signalling pathways stimulate contractile responses by G protein-
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coupled receptors. One of the most-studied GPCRs is the β2-AR, which ususally mediates 
relaxation in different smooth muscles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Contraction and relaxation in smooth muscle cells. (Paulev et Zubieta-Callej 
2004) 
 
Relaxation is brought about predominantly by stimulation of Gs-protein-coupled adenylyl 
cyclase (AC), which enzyme catalyses the breakdown of ATP to cAMP. Increased levels of 
cAMP are therefore responsible for the β2-AR-mediated relaxation of smooth muscle (Xiao et 
al. 2006). The stimulation of β2-AR has therapeutic importance in relaxation of the bronchial 
tract (bronchial asthma) and the pregnant uterus (preterm birth) (Cazzola et al., 2013, Gáspár 
et al., 2005). For both, one of the most frequently used betamimetics is terbutaline, although 
its use in threatened preterm labor is strongly debated (Sayed et al., 2013, Dodd et al., 2012).  
1.3. Hormonal effects on β2-ARs 
Sex hormones play role in the regulation of G-proteins of β2-ARs in the myometrial, cervical 
and tracheal smooth muscles. Previous studies have demonstrated that acute estradiol 
(E2) administration can induce protein kinase G dependent relaxation in the cardiovascular 
system mediated by cAMP. (Keung et al 2011). The colocalization of β2-AR and estrogen 
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receptors (ER) may play a role in the interaction between these receptors in potentiating 
relaxation. Furthermore, both estrogens and β2-AR activate a common mechanism, 
cAMP/PKA, raising the possibility of using estrogens to enhance β2-AR agonist effects to 
induce bronchodilation (Townsend et al. 2012). It is a potentially novel route for enhancing 
β2-AR-induced bronchodilation by modulation of estrogen signaling. The relevance of such 
pathway lies in the possibility of reducing β2-AR utilization and thus desensitization. 
Clinically relevant concentrations of estrogen can potentiate β2-AR-induced reduction in 
intracellular calcium of airway smooth muscle, as well as relaxation. 
Earlier findings suggested that P4 play a role in the regulation of G-proteins in the 
myometrium (Elwardy et al. 1994). The presence of progesterone is a determining factor for 
the pregnant uterine-relaxing action of terbutaline. This correlation can be explained by the 
β2-AR density increasing effect of progesterone. Importantly, P4 treatment causes an 
elevation in the number of myometrial β2-ARs (Gaspar et al. 2005). Thus, higher progesterone 
level means better G-protein activation and a stronger inhibitory action of betamimetics on 
myometrial contractions. Theoretically, when the signal mechanism is increased, the linked 
ROS production should also be increased. 
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2.Aims of the study 
 
 
The main focus of our study was to investigate how antioxidant agents alter the β2-AR 
signaling and contractility in uterine and tracheal smooth muscles in rats. 
 
1. The first aim was the study to investigate the separate effects of tocopherol or limonene on 
pregnant rat myometrium and cervix, and on trachea from non-pregnant rat. Myometrial 
contractions, cervical and tracheal tones were measured in organ bath. 
 
2. Since ROS have a role in cell-signaling of cardiac muscle, our further aim was to 
investigate how tocopherol or limonene may alter the effect of terbutaline on myometrial, 
cervical and tracheal smooth muscle contractility or tones. 
3. The sexual hormones influence the activity of β2-ARs. While progesterone enhances the 
receptor function in the uterus, the estrogen increases the receptor activity in the trachea. 
Therefore our next aim was to reveal the consequences of sexual hormon pre-treatment on the 
β2-AR-mediated smooth muscle response in the presence of antioxidants. 
 
4.  Our last aim was to clarify the reasons of the possible differences in response among the 
smooth muscle tissues toward the modifying action of tocopherol or limonene during β2-
agonist action. The cAMP and oxidative status of the smooth muscles were investigated by 
ELISA method.  
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3. Materials and methods 
 
3.1. Housing and handling of the animals 
The animals were treated in accordance with the European Communities Council directives 
(86/609/EEC) and the Hungarian Act for the protection of animals in research 
(XXVIII.tv.32.§). All experiments involving animal subjects were carried out with the 
approval of the Hungarian Ethical Committee for Animal Research (permission number: 
IV./198/2013). Sprague-Dawley rats were kept at 22 ± 3 ºC, with a relative humidity of 30-
70%, under a lights-darkness cycle of 12 h : 12 h. The animals were maintained on a standard 
rodent pellet diet (Charles-River Laboratories, Budapest, Hungary), with tap water available 
ad libitum. The animals were terminated by CO2 inhalation. 
Mating of the animals 
Mature female Sprague-Dawley rats in estrus were collected. The estrous cycle was detected 
by measurement of the vaginal impedance with an Estrus Cycle Monitor EC40 (Fine Science 
Tools, Foster City, CA, USA). The selected female and male rats were mated in a special 
mating cage. A metal door separated the rooms for the male and the female animals. The 
separating door was opened before dawn by a small electric engine controlled by a timer. In 
the morning, within 4-5 h after the possible mating, vaginal smears were taken from the 
female rats. Copulation was determined by the presence of a copulation plug or the presence 
of sperms in a native vaginal smear. The day of conception was regarded as the first day of 
pregnancy. 
3.2. In vivo sexual hormone treatments of the rats 
The progesterone (P4) treatment of the pregnant animals (n=8) was started on day 15 of 
pregnancy. P4 was dissolved in olive oil and injected subcutaneously every day up to day 21 
at 0.5 mg/0.1 ml. On day 22, the uteri were collected and the contractility and molecular 
pharmacological studies were carried out as described below. 
The estrogen treatment was started with non-ovariectomized female rats (n=8) in the estrous 
phase. The animals were injected subcutaneously with 5 μg/kg of 17βestradiol-valerate (E2) 
dissolved in olive oil once a day for a period of 4 days. 
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3.3. Determination of myometrial, cervical and tracheal β2-AR mRNA by real-time reverse 
transcription-PCR and Western blot 
Tissue isolation. The myometria, cervices from pregnant rats (day 22) and the trachea from 
female rats in estrous cycle were rapidly removed and placed in RNAlater Solution (Sigma-
Aldrich, Hungary). The tissues were frozen in liquid nitrogen and then stored at -70 °C until 
the extraction of total RNA. 
Total RNA preparation. Total cellular RNA was isolated by extraction with guanidinium 
thiocyanate-acid-phenol-chloroform according to the procedure of Chomczynski and Sacchi 
(1987). After precipitation with isopropanol, the RNA was washed with 75% ethanol and then 
resuspended in diethyl pyrocarbonate-treated water. RNA purity was controlled at an optical 
density of 260/280 nm with BioSpec Nano (Shimadzu, Japan); all samples exhibited an 
absorbance ratio in the range 1.6-2.0. RNA quality and integrity were assessed by agarose gel 
electrophoresis.  
Real-time quantitative reverse transcription-PCR (RT-PCR). Reverse transcription and 
amplification of the PCR products was performed by using the TaqMan RNA-to-CT
TM
 1-Step 
Kit (Life Technologies, Hungary) and the ABI StepOne Real-Time cycler. RT-PCR 
amplifications were performed as follows: 48 °C for 15 min and 95 °C for 10 min, followed 
by 40 cycles at 95 °C for 15 sec and 60 °C for 1 min. The generation of specific PCR products 
was confirmed by melting curve analysis. The following primers were used: assay ID 
Rn00560650_s1 for 2-adrenergic receptor and Rn00667869-m1 for ß-actin as endogenous 
control. All samples were run in triplicates. The fluorescence intensities of the probes were 
plotted against PCR cycle numbers. The amplification cycle displaying the first significant 
increase of the fluorescence signal was defined as the threshold cycle (CT).  
Western blot analysis of myometrial, cervical and tracheal β2-ARs 
50 g of protein per well was subjected to electrophoresis on 4-12% NuPAGE Bis-Tris Gel in 
XCell SureLock Mini-Cell Units (Life Technologies, Hungary). Proteins were transferred 
from gels to nitrocellulose membranes, using the iBlot Gel Transfer System (Life 
Technologies, Hungary). The antibody binding was detected with the WesternBreeze 
Chromogenic Western blot immundetection kit (Life Technologies, Hungary). The blots were 
incubated on a shaker with 2-adrenergic receptor and -actin polyclonal antibody (Santa 
Cruz Biotechnology, California, 1:200) in the blocking buffer. Images were captured with the 
EDAS290 imaging system (Csertex Ltd., Hungary), and the optical density of each 
immunoreactive band was determined with Kodak 1D Images analysis software. Optical 
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densities were calculated as arbitrary units after local area background subtraction.  
3.4. In vitro contractility studies 
Myometrial rings were dissected from the horns of nontreated (n=8) and P4-treated 22-day-
pregnant rats (n=8). Muscle rings 5 mm long were mounted vertically in an organ bath 
containing 10 ml de Jongh solution (composition in mM: 137 NaCl, 3 KCl, 1 CaCl2, 1 MgCl2, 
12 NaHCO3, 4 NaH2PO4, 6 glucose, pH 7.4). The organ bath was maintained at 37 °C and 
carbogen (95% O2 + 5% CO2) was bubbled through it. The initial tension of the preparation 
was set to about 1.5 g. After mounting, the rings were equilibrated with a solution change 
every 15 min for about 1 h before the experiments were undertaken. After the equilibration 
period, the myometrial rings were incubated for another 60 min with tocopherol (10
-7 
M) or 
limonene (10
-13 
M). The tissues were washed and further tocopherol or limonene was 
administered every 15 min. The control samples were incubated for 1 h without antioxidants. 
A dose-response curve of 10
-10
 - 10
-5 
M terbutaline was obtained in a cumulative manner 
Cervical tissues of nontreated (n=8) and P4-treated 22-day-pregnant rats (n=8) were removed 
on pregnancy day 22. Two cervical rings were separated and mounted (with their longitudinal 
axis vertically) by hooks in an organ bath containing 10 ml de Jongh buffer. The initial 
tension was set to about 1.00 g. After mounting, the rings were equilibrated for 1 h, and then 
another 1 h with tocopherol (10
-7 
M) before the experiments was undertaken, with a buffer 
and tocopherol change every 15 min. The control samples were incubated for 1 h without 
tocopherol. Terbutaline (10
-6 
M) was added to the organ bath and the cervices were incubated 
for 5 min. The cervices were stretched in incremental steps and allowed to relax for 5 min. 
After every 5 min, the next initial tension was set, in 1-g steps between 1 and 10 g. The 
tension was increased manually via the control screw of a gauge transducer. The resultant 
stress-strain curves had a sawtooth shape. In the evaluation of the cervical resistance, the 
initial tension of the cervix was plotted versus the stretch after 5 min. Straight lines were fitted 
by linear regression and the slopes of the lines were used to express the degree of resistance. 
A steeper slope reflected a higher resistance (Gaspar et al. 2005). 
Trachea tissues were dissected from female rats (160-260 g, n=8) in the estrous phase. The 
isolated trachea was cut transversally into small rings, which were placed in Krebs solution 
(composition in mM: 118 NaCl; 4.75 KCl; 2.5 CaCl2; 1.19 K2HPO4; 25 NaHCO3; 1.2 
MgSO4; and 11 glucose). The tracheal tube was cut into rings 4–5 mm wide, which were 
mounted with their longitudinal axis vertically by hooks. The initial tension was set to about 
2.00 g. The tissue was incubated for 60 min. The buffer solution was renewed every 15 min. 
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After the equilibration period, the tracheal muscle preparation was incubated with tocopherol 
(10
-7 
M)/limonene (10
-13 
M) for another 60 min with renewal of the buffer solution and the 
administration of further tocopherol or limonene every 15 min. The control samples were 
incubated for 1 h without tocopherol. A cumulative dose−response curve of 10-9 - 10-4 M 
terbutaline was obtained. 
The myometrial, cervical and tracheal activities were measured with a gauge transducer (SG-
02, Experimetria Ltd, Budapest, Hungary) and recorded with a SPEL Advanced ISOSYS Data 
Acquisition System (Experimetria Ltd, Budapest, Hungary). 
 
3.5. Measurement of cAMP accumulation and total oxidant and antioxidant status 
Measurement of cAMP accumulation 
The tissue samples (myometrium, cervix and trachea, n=6/group) were incubated in an organ 
bath as described above. The effects of terbutaline (10
−6 
M) and/or tocopherol (10
−7 
M) on 
cAMP accumulation were detected in the presence of the nonspecific phosphodiesterase 
inhibitor 3-isobutyl-1-methylxanthine (10
−3 
M) and the adenylyl cyclase activator forskolin 
(10
−5 
M). Tocopherol/limonene incubation was performed 1 h before terbutaline treatment. 
Terbutaline was added to the samples for 10 min. The samples were then immediately frozen 
in liquid nitrogen and stored until the extraction of cAMP (Gáspár et al. 2007). Frozen tissue 
samples were ground, weighed, homogenized in 10 volumes of ice-cold 5% trichloroacetic 
acid, and centrifuged at 1000 g for 10 min. The supernatants were extracted with three 
volumes of water-saturated diethyl ether. After drying, the extracts were stored at −70 °C until 
the cAMP assay. Tissue cAMP accumulation was measured with a commercial competitive 
cAMP enzyme immunoassay kit (Cayman Chemical Company, Ann Arbor, Michigan, USA), 
and expressed as pmol/mg tissue.  
Measurements of total oxidant and antioxidant status 
The myometrial, cervical and tracheal tissues of rats (n=6/group) were excised and rinsed 
with ice-cold saline. Tissue homogenates were prepared from a known amount of tissues, 
homogenized in 10% (w/v) 20 mM Tris-HCl buffer, pH 7.4 at 4 °C, with an IKA Ultra-Turrax 
T-25 Digital Homogenizer (Janke & Kunkel, Staufen, Germany). The homogenates were 
centrifuged at 5000  g for 10 min at 4 °C. The supernatant was collected as tissue 
homogenate, and was used for the biochemical estimations (Unal et al. 2012). 
The total oxidant status (TOS) was measured with a kit provided by RelAssay Diagnostics 
(Gaziantep, Turkey). Oxidants present in the sample oxidize the ferrous ion–o-dianisidine 
15 
 
complex to ferric ion. The oxidation reaction is enhanced by glycerol molecules, which are 
abundantly present in the reaction medium. The ferric ion yields a colored complex with 
xylenol orange in an acidic medium. The color intensity, which can be measured 
spectrophotometrically at 530 nm, is proportional to the total amount of oxidant molecules 
present in the sample. The assay is calibrated with hydrogen peroxide and the results are 
expressed in terms of μmol H2O2 equiv./L. The assay characteristics were described earlier 
(Erel 2005). 
The total antioxidant status (TAS) was measured with a 3
rd
-generation kit provided by 
RelAssay Diagnostics (Gaziantep, Turkey). Antioxidants in the sample reduce the dark blue-
green ABTS radical to the colorless ABTS form. The change in absorbance at 660 nm is 
proportional to the total antioxidant level of the sample. The assay is calibrated with a 
standard stable antioxidant solution, traditionally referred to as Trolox equivalent, which is a 
vitamin E analog. The assay characteristics were described earlier (Erel 2004). 
The oxidative stress index (OSI) was defined as the ratio of TOS and TAS. A standardized 
value does not exist for OSI levels, which were used only for comparisons. OSI was 
calculated via the formula OSI (arbitrary unit) = TOS (µmol H2O2 equiv./L)/TAS (mmol 
Trolox equiv/L) (Erel 2004). 
3.6. Statistical analysis 
All data were analyzed with the Prism 4.0 (GraphPad Software, USA) computer program, and 
the values were statistically evaluated with the unpaired t-test or with ANOVA with Dunnett’s 
Multiple Comparison Test. 
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4. Results 
4.1. Effect of D-limonene and tocoherol on smooth muscle contractility 
 
D-limonene caused myometrial contraction in a dose-dependent manner (Fig.2.) The 
compound has no effect on cervical resistance and on tracheal tone (result is not shown).     
Tocopherol at 10
-7
 M did not significantly alter the myometrial contractions, cervical 
resistance or tracheal tone (result is not shown). 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The effect of D-limonene (10
-13
 – 10-8M) on 22 day pregnant rat myometrial contraction, in 
vitro. (n=6)  
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4.2. Effects of tocopherol and limonene on the myometrial action of terbutaline  
Terbutaline elicited a concentration-dependent inhibitory effect on the spontaneous 
contractions of the 22-day-pregnant myometria. The presence of tocopherol (10
-7 
M) did not 
change the effect of terbutaline in either non-treated or P4-treated tissues (Fig. 3.). The 
concentration−response curve of terbutaline (EC50: 1.1x10
-7
 ± 0.6 x10-8 M) was shifted to the 
left for myometrial samples from P4-pretreated animals (EC50: 2.2x10
-8
 ± 1.4 x10-8 M). The 
progesterone treatment did not alter the expression of 2-AR mRNA in pregnant myometria. 
However, the Western blot study revealed that the progesterone treatment increased the 
expressions of 2-ARs in the uterine tissues, respectively (Fig. 4.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effects of terbutaline on spontaneous contractions of nontreated and P4-pretreated 22-day-
pregnant rat myometria, alone and in the presence of tocopherol (10
-7 
M). The concentration−response 
curve of terbutaline was shifted to the left by P4-pretreatment (black lines). The presence of 
tocopherol did not change the effects of terbutaline (red lines) 
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Figure  4. β2 receptor expression in rat myometrium, cervix és trachea. (n=6) *: p<0,05, ***p<0.001 
P4M: P4-treated myometrium, M: myometrium 
P4C: P4-treated cervix, C: cervix 
E2T: E2-treated trachea, T: trachea 
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D-limonene (10−13-10−8 M) enhanced the myometrial contractions in concentration dependent 
manner. In the presence of d-limonene (10−13 M) the concentration−response curve of 
terbutaline was shifted to the left; however the maximal effect of terbutaline remained 
unchanged (Table 1.). The P4 treatment enforced the terbutaline effect on myometrial 
relaxation, but the D-limonene did not modify the concentration-response curve of terbutaline 
(Fig. 5.).     
 
Table 1. Parameters of concentration-response curve of terbutaline in non-treated (a) and in 
P4-treated (b) myometrium in the presence or absence of limonene  
a. 
Non-treated myometria EC50 (M±S.E.M) Emax (M±S.E.M.) 
terbutaline 1,4x10
-7 ±3,7x10-8 93,7% ± 4,8 
limonene+terbutaline 6,5x10
-9 ±1,48x10-9** 95,4% ± 1,6 ns 
 
b. 
P4-treated myometria EC50 (M±S.E.M) Emax (M±S.E.M.) 
terbutaline 8,6 x 10
-8
 ±3,35x10-8 88,5% ± 3,7 
limonene+terbutaline 4,9 x 10
-7 ±2,56x10-7 ns 89,5% ± 6,3 ns 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Effects of terbutaline on spontaneous contractions of nontreated and P4-pretreated 22-day-
pregnant rat myometria, alone (black lines) and in the presence of limonene (10
-13 
M) (red lines).  
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Terbutaline (10
-6 
M) increased the cAMP level in the nontreated myometria. The presence of 
tocopherol (10
-7 
M) did not alter the myometrial cAMP level induced by terbutaline (Fig. 6.).  
In the P4-treated myometria, the terbutaline-induced increase in cAMP level was higher 
(12.7% increase, p<0.05) as compared with nontreated samples, but tocopherol again 
remained ineffective (Fig. 6.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. The myometrial cAMP level-increasing effect of terbutaline in the absence or presence of 
tocopherol. Terbutaline treatment (10
-6 
M) increased the cAMP level in the myometrium; tocopherol 
(10
-7 
M) was ineffective on this action. In P4-pretreated animals, terbutaline further increased the 
myometrial cAMP, but tocopherol did not elicit any effect. 
ns: not significant, *p<0.05; **p<0,01 as compared with the control pair 
 
 
 
4.3. Effects of tocopherol and limonene on the cervical action of terbutaline 
Terbutaline (10
-6 
M) enhanced the cervical resistance of 22-day-pregnant cervical samples 
(0.96 ± 0.02) as compared with the control value (0.82 ± 0.02). Tocopherol (10-7 M) and D-
limonene (10
-13 
M) did not significantly alter the cervical resistance-increasing effect of 
terbutaline (0.92 ± 0.01) (Fig. 7.). 
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Figure 7. Effects of terbutaline on the resistance of nontreated 22-day-pregnant rat cervices, alone and 
in the presence of tocopherol (A) and limonene (B). Resistance is expressed as the slope of the 
regression lines fitted to the stress−strain curves. Terbutaline (10-6 M) increased the cervical resistance, 
the effect was not altered neither by tocopherol (10
-7 
M) nor limonene (10
-13 
M). *p<0.05; **p<0.01 as 
compared with the control pair 
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P4 pretreatment increased the cervical resistance (0.89 ± 0.02, p<0.05) and left the resistance-
increasing action of terbutaline unchanged (0.96 ± 0.01). However, the presence of 
tocopherol, and also D-limonene eliminated the effect of terbutaline in P4-pretreated cervical 
samples (Fig. 8.). The progesterone treatment did not altered the expression of 2-AR mRNA 
in pregnant cervices (Fig. 4.). 
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Figure 8. Effects of terbutaline on the resistance of P4-pretreated 22-day-pregnant rat cervices, alone 
and in the presence of tocopherol (A) and limonene (B). Resistance is expressed as the slope of the 
regression lines fitted to the stress−strain curves. In vivo P4-pretreatment did not increase the cervical 
resistance-increasing effect of terbutaline further, but tocopherol and also limonene blocked the action 
of terbutaline. ns: not significant; *p<0.05; ***p<0.001 as compared with the control pair 
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Terbutaline (10
-6 
M) elevated the cAMP content in the pregnant cervical tissues. In the 
presence of tocopherol, there were no further changes in cAMP level. After P4 pretreatment, 
the cervical cAMP was elevated by terbutaline as compared with nontreated samples, and 
tocopherol was able to block the cervical resistance-increasing effect of terbutaline. The level 
of cAMP induced by terbutaline was increased in the P4-treated samples (10.9% increase, 
p<0.001)(Fig. 9.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.  The cervical cAMP level-increasing effect of terbutaline in the absence or presence of 
tocopherol. Cervical samples were collected from 22-day-pregnant rats. Terbutaline treatment (10
-6 
M) 
increased the cAMP level in the cervix, but tocopherol (10
-7 
M) was ineffective. In P4-pretreated 
animals, terbutaline further increased the cervical cAMP, while this effect was reduced significantly 
by tocopherol. 
ns: not significant; ***p<0.001 as compared with the control pair. 
 
4.4. Effects of tocopherol and limonene on the tracheal action of terbutaline  
Terbutaline (10
-9 
M – 10-4 M) decreased the tone of tracheal segments with an average of 56 ± 
3 mg. In the presence of tocopherol (10
-7 
M), the relaxing effect of terbutaline was reduced 
significantly (24 ± 3 mg) (Fig. 10.A.). D-limonene (10-13 M) also reduced the relaxing effect 
of terbutaline (Fig. 10.B.). After in vivo E2-pretreatment, the tracheal tone-reducing effect of 
terbutaline was stronger (74 ± 7 mg), but the presence of tocopherol led to the same reduction 
as in nontreated samples (24 ± 4 mg) (Fig. 11.A.). In the case of d-limonene, the reducing 
effect was also enhanced (Fig. 11.B). The estrogen treatment enhanced the expression of the 
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receptor mRNA in the trachea. The Western blot study revealed that the estrogen treatment 
increased the expressions of 2-ARs in tracheal tissues, respectively (Fig. 4.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Tone-reducing effect of terbutaline on isolated rat tracheal preparations, with or without 
tocopherol. Tracheal samples were collected from female rats in the estrous cycle. (A) In the presence 
of tocopherol (10
-7 
M), the effect of terbutaline was significantly decreased. (B) After in vivo E2-
treatment, the relaxing effect of terbutaline was even higher. Tocopherol decreased the effect of 
terbutaline measured without E2-pretreatment. *p<0.05; **p<0.01; ***p<0,001 as compared with 
terbutaline effect alone 
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Figure 11. Tone-reducing effect of terbutaline on isolated rat tracheal preparations, with or without 
limonene. Tracheal samples were collected from female rats in the estrous cycle. (A) In the presence 
of limonene (10
-13 
M), the effect of terbutaline was significantly decreased. (B) After in vivo E2-
treatment, the relaxing effect of terbutaline was even higher. Limonene decreased the effect of 
terbutaline measured without E2-pretreatment. *p<0.05; as compared with terbutaline effect alone 
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In the tracheal smooth muscle, the cAMP content was elevated by terbutaline (10
-5 
M) both in 
nontreated and in E2-treated samples (Fig.12.). The level of cAMP induced by terbutaline 
was increased in the E2-treated samples (30.0% increase, p<0.05). Tocopherol inhibited the 
action of terbutaline in both cases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. The tracheal cAMP level-increasing effect of terbutaline in the absence or presence of 
tocopherol. Tracheal samples were collected from female rats in the estrous cycle. Terbutaline 
treatment (10
-5 
M) increased the cAMP level in the trachea. In the presence of tocopherol (10
-7 
M), the 
effect of terbutaline was reduced. In E2-pretreated animals, terbutaline further increased the tracheal 
cAMP. The inhibitory effect of tocopherol was more pronounced as compared with non-E2-treated 
samples. 
ns: not significant, ***p<0.001 as compared with the control pair. 
 
4.5. Oxidative and antioxidative status of myometrial, cervical and tracheal smooth muscles 
TOS was lowest in the pregnant myometrium, and highest in the trachea. The pregnant 
cervical TOS value was higher than the pregnant myometrial value. The TOS values of the 
nonpregnant myometrium and cervix were similar to those for the pregnant samples. TAS was 
highest in the pregnant myometrium, and lowest in the trachea. The TAS values of the 
nonpregnant myometrium and cervix were lower than those for the pregnant samples (Fig. 
13.A.). OSI (TOS/TAS) was lowest in the pregnant myometrium, and highest in the trachea. 
The OSI value of the pregnant cervical cervix was lower than those for the nonpregnant 
sample (Fig. 13.B.). 
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Figure 13. The oxidative/antioxidant status in the myometriual, cervical and tracheal tissues (empty 
columns). Nonpregnant samples and trachea were collected from female rats in the estrous cycle. 
(filled columns). The total oxidative status (TOS) values of trachea and pregnant cervix were 
significantly higher as compared with pregnant myometrial value. The differences between the 
pregnant and nonpregnant tissues were nonsignificant. (A) The total antioxidant status (TAS) values 
were the lowest in the trachea and the highest in the pregnant myometrium. The differences between 
the pregnant and nonpregnant tissues were significant. The oxidative stress index (OSI) was calculated 
as the ratio of TOS and TAS. The OSI was highest in the trachea and lowest in the pregnant 
myometrium. (B) 
mi: myometrium, ce: cervix, tr: trachea 
*p<0.05; **p<0.01; ***p<0.001 as compared with the pregnant myometrial values 
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 5. Discussion 
 
ROS are generated during crucial processes of O2 consumption. Under physiological 
conditions, there is a balance between the mitochondrial production of ROS and the 
antioxidant systems. ROS seem to act as second messengers of specific ligands, including 
different growth factors and adrenergic signaling (Corbi et al, 2013). We therefore 
hypothesized that an antioxidant effect may interact with the signal mechanism of β-ARs. 
Since β2-ARs are of therapeutic importance in the relaxation of uterine and bronchial smooth 
muscles, we examined whether the antioxidant agents alter the beta-mimetic action in these 
tissues. The significance of this investigation is enhanced by the fact that patients often 
consume abundant multivitamin and antioxidant supplements containing tocopherol 
derivatives in order to improve or maintain their general health condition (Huang et al. 2006). 
Tocopherol appears to have a wide range of effects on cellular systems, with the ability to 
inhibit protein kinase C, activate diacylglycerol kinase and protein phosphatase 2A (Azzi et 
al. 2000), and regulate specific gene expression (Rimbach et al. 2010); in this way, tocopherol 
can influence a number of biological functions and metabolisms. Additionaly, the antioxidant 
effects of terpenoids are also known (Grassmann et al. 2005), and D-limonene is widely used 
as flavour and fragrance. 
Therefore our aim was to investigate the effect of these agents alone and on beta-mimetic 
action. D-limonene caused myometrial contraction in a dose-dependant manner, while 
tocopherol had no signifiant action. Like numerous cell membrane receptors, β2-ARs are 
coupled to their eﬀector units via G-proteins. Traditionally, signal transduction by the β2-ARs 
has focused largely on the activation of Gs proteins and their downstream effectors, including 
cAMP-generation AC. cAMP and its effectors are considered to be the chief mediators of the 
cell response to β2-AR activation (Lefkowitz and Shenoy 2005). However, GPCRs, including 
β-ARs, have also been found to regulate the production of ROS, which determine the nature 
and duration of the cell signal (Andersson et al. 2011). As a β2-AR agonist, terbutaline was 
added to last-day-pregnant myometrial and cervical rat tissue, and to tracheal samples from 
estrous phase female rats in an organ bath. The responses of the tissues were in harmony with 
the literature data: the myometrium was relaxed, the cervical resistance was increased, and the 
tracheal tone was reduced (Gaspar et al. 2005; Gaspar et al. 2007, Chou et al. 2010). In the 
presence of the antioxidant agents the effect of terbutaline was reduced only in the case of the 
trachea, while the uterine (myometrium and cervix) responses were unchanged. These results 
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indicate that differences may occur in the ROS dependence of the β2-AR signal mechanism in 
different smooth muscles. 
Sexualhormones are known to play a role in the regulation of G-proteins of β2-ARs in the 
myometrial, cervical and tracheal smooth muscles. P4 enhances the signaling of myometrial 
and cervical β2-ARs (Elwardy et al. 1994), while E2 is able to increase the second messenger 
processes in airway smooth muscles (Townsend et al. 2012). Theoretically, when the signal 
mechanism is increased, the linked ROS production should also be increased. Pregnant 
animals were therefore treated with P4 for 7 days to stimulate the β2-AR signaling in the 
myometrium and the cervix (Gaspar et al. 2005), while nonpregnant rats were treated with E2 
for 4 days (Song et al. 2002) in order to increase the β2-AR signaling in the tracheal tissue. 
Although the P4 treatment was not able to increase the myometrial and cervical mRNA 
expressions of β2-AR, the increase in protein expression was significant. The E2 treatment 
was able to elevate both the expressions of tracheal mRNA and protein. The increased 
receptor function, and signal mechanism were also proved by the enhanced cAMP levels in 
hormone-treated samples after terbutaline administration as compared with the hormonally 
nontreated tissues. After the hormonal induction of the β2-AR signal in the myometrium, 
tocopherol and limonene still remained ineffective on the action of terbutaline. However, the 
antioxidants significantly reduced the cervical response to terbutaline, and a further decline 
was found in the trachea. These changes were supported by the altered intracellular cAMP 
productions of the tissues. These findings suggest that ROS are necessary for the β2-AR-
linked cAMP production in the trachea and in the hormonally induced cervix, while their 
contribution is not so important in the pregnant myometrium. The differences observed 
between these tissues raised the possibility of the tissue-specific regulation of ROS production 
after β2-AR stimulation. 
The ROS and productions of a given tissue can be characterized by the determination of TOS 
and TAS, the ratio of which gives the OSI, an accepted parameter of the oxidative status 
(Bozkus et al. 2013, Ellidag et al. 2013). Although our method was not able to distinguish 
between the ROS and the free radicals, earlier studies showed the predominance of ROS in 
uterine and tracheal processes (Badziuk et al., 2011, Loukides S et al., 2011). In our studies 
the highest OSI was found in the trachea and the lowest in the pregnant myometrium. The 
terbutaline-induced relaxation was inhibited most strongly by tocopherol and limonene in the 
trachea, where the OSI was highest. On the other hand, the antioxidants were ineffective in 
the pregnant myometrium, which has the lowest oxidative stress level. This means that the 
ROS/free radicals dependence of the β2-AR signal varies with the localization and function of 
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the smooth muscles. It is not yet known which steps of the second messenger mechanisms 
require the presence of ROS/free radicals to provide uninterrupted intracellular signals. Our 
results suggest that a high OSI in a tissue implies a higher importance of ROS/free radicals in 
the signal mechanism of β2-AR. 
The OSI values of the nonpregnant myometrium and cervix were higher as compared with the 
pregnant samples (although the difference was not significant in case of myometria). This 
result reconfirms the earlier findings of upregulation of antioxidant enzymes during 
pregnancy. (Kaya S. et al, 2013). 
6. Conclusion 
 
We suppose that stimulation of β2-AR leads to formation of ROS, and that ROS play key role 
in receptor coupling to G proteins, as well as expression of receptor on the plasma membrane. 
Thus the generation of ROS seem to be essential for ‘classical’ receptor-mediated signaling 
events. Antioxidants are able to reduce the coupling of β2-ARs that may lead to the weakening 
of the smooth muscle action of β2-AR agonists. The up-regulation of the receptors means the 
up-regulation of ROS production as well. However, the extend of the role of ROS in β2-AR 
signaling is mainly depends on the oxidative stress index of the given smooth muscle. Our 
finding suggests that significant decrease in β2-AR agonist effect by antioxidants might be 
possible in the antiasthmathic therapy.  
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